This trialwill investigate if the dose of a drug (TXA) given to pregnant women at the time of delivery affects the concentration of the drug in their blood.
- Postpartum Hemorrhage
2 Primary · 0 Secondary · Reporting Duration: 2 years
Side Effects for
Awards & Highlights
4 Treatment Groups
1 of 4
1 of 4
1 of 4
1 of 4
120 Total Participants · 4 Treatment Groups
Primary Treatment: Morbidly Obese · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18 - 50 · Female Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does the FDA sanction Morbidly Obese as a viable treatment option?
"Morbidly Obese received a score of 3, as there is clinical evidence to suggest efficacy and rounds of data which attest the safety." - Anonymous Online Contributor
Does the protocol of this experiment permit participation from adults?
"The parameters for this trial only permit those aged 18 to 50. Alternatively, 53 trials are available for minors and 283 studies are open to patients over 65 years old." - Anonymous Online Contributor
Are there any openings available to join this trial?
"Correct. According to clinicaltrials.gov, this study was officially opened on December 28th 2022 and is currently recruiting participants from one site with a desired sample size of 120 individuals." - Anonymous Online Contributor
What is the current number of volunteers for this research endeavor?
"Affirmative, data found on clinicaltrials.gov confirms that the trial is actively enrolling patients. It was initially announced on December 28th 2022 and most recently updated January 23rd 2023 with a target of 120 participants across one site." - Anonymous Online Contributor
Do I fulfill the prerequisites to join this clinical examination?
"This study seeks 120 individuals with postpartum hemorrhage that are between 18 and 50 in age. To be eligible for the trial, women must meet these qualifications: undergoing elective or non-urgent cesarean delivery greater than 34+0 weeks gestation; at > 34 weeks of gestation during a vaginal delivery; morbidly obese (BMI > 50) through either a vaginal or cesarean delivery; aged between 18 to 50 years old; normal serum creatinine levels (< 0.9)." - Anonymous Online Contributor